PFSMF vs AAPL: Which Stock is Better?
Side-by-side comparison of Perfect Medical Health Management Limited and Apple Inc in 2026
PFSMF
Perfect Medical Health Management Limited
$0.24
AAPL
Apple Inc
$269.84
Key Metrics Comparison
| Metric | PFSMF | AAPL | Winner |
|---|---|---|---|
| Market Cap | $301.61M | N/A | PFSMF |
| P/E Ratio | 12.01 | 33.32 | PFSMF |
| EPS (TTM) | $0.02 | $8.11 | AAPL |
| Revenue Growth | -0.2% | 0.2% | AAPL |
| Gross Margin | 62.5% | 47.3% | PFSMF |
Analyze PFSMF
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PFSMF or AAPL a better investment?
Comparing PFSMF and AAPL: Perfect Medical Health Management Limited has a market cap of $301.61M while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PFSMF and AAPL?
PFSMF (Perfect Medical Health Management Limited) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PFSMF or AAPL?
Based on P/E ratios, PFSMF trades at a lower multiple (12.0x vs 33.3x).
Which is growing faster: PFSMF or AAPL?
AAPL has higher revenue growth at 0.2% vs -0.2% for PFSMF.
Which company is more profitable: PFSMF or AAPL?
Perfect Medical Health Management Limited (PFSMF) has higher gross margins at 62.5% compared to 47.3% for AAPL.
Which is the larger company: PFSMF or AAPL?
Perfect Medical Health Management Limited (PFSMF) is larger with a market cap of $301.61M compared to N/A for AAPL.
Should I buy PFSMF or AAPL in 2026?
Both PFSMF and AAPL have investment merit. PFSMF trades at $0.24 while AAPL trades at $269.84. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PFSMF and AAPL stock?
Key differences: Market Cap ($301.61M vs N/A), P/E Ratio (12.0x vs 33.3x), Revenue Growth (-0.2% vs 0.2%), Gross Margin (62.5% vs 47.3%).